Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Active not recruiting 4Terminated 2Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 12Gastrointestinal 4Breast 4Sarcoma 2Lymphoid 1Head & Neck 1Gynecologic 1

Conditions

Sarcoma 2Melanoma 1

Interventions

Radiotherapy 144Doxorubicin 112Temozolomide 110Cyclophosphamide 110Filgrastim 79Ifosfamide 70Imatinib Mesylate 69Etoposide 69Bevacizumab 55Vincristine 51Gemcitabine 50Peripheral Blood Stem Cell Transplantation 47Irinotecan 43Methotrexate 39Cisplatin 36Carboplatin 36Radiation 35fludarabine phosphate 34Busulfan 34pazopanib 32Sirolimus 30Melphalan 30Trabectedin 29Docetaxel 27Chemotherapy, Adjuvant 27Cyclosporine 25Carmustine 25sargramostim 24Surgical Procedures, Operative 23Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × talimogene laherparepvec × Sarcoma × Clear all
NCT02453191 2024-06-20

TVEC and Preop Radiation for Sarcoma (4 ml Dose)

University of Iowa

Phase 1/2 Completed
30 enrolled 12 charts
Sarcoma

Sarcoma

NCT03555032 2021-08-18

TITAN

Royal Marsden NHS Foundation Trust

Phase 1/2 Completed
15 enrolled
DermatologicSarcoma

Melanoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡